Clinical Impact of Discordant Minimal Residual Disease Assessment in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation
{{output}}
Background: Measurable residual disease (MRD) is a key prognostic marker in adult B-cell precursor acute lymphoblastic leukemia (B-ALL), yet inter-assay discordance may complicate MRD-guided decisions, particularly around allogen... ...
